Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Melissa Pearson

Physician Assistant Rockwall, TX Physician Assistant

NPI 1003291246 CMS profile 11122140

2701 Sunset Ridge Dr Ste 200, Rockwall, TX 75032

Open in the dashboard

General payments

$8,137

377 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Melissa Pearson of Rockwall, TX is reported in the CMS Open Payments database as having received $8,137 across 377 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,440 78
2024 General $2,181 93
2023 General $1,692 92
2022 General $2,247 79
2021 General $577 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Melissa Pearson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Melissa Pearson were reported at $1,440. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Melissa Pearson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $577 $132 $37–$438 $132
2022 $2,247 $155 $48–$522 $149
2023 $1,692 $167 $52–$557 $160
2024 $2,181 $178 $55–$600 $164
2025 $1,440 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Biohaven Pharmaceutical Holding Company Ltd. $1,158 12 payments
  2. Novo Nordisk Inc $672 39 payments
  3. Abbott Laboratories $584 30 payments
  4. GlaxoSmithKline, LLC. $553 33 payments
  5. Lilly USA, LLC $548 37 payments
  6. Amgen Inc. $511 30 payments
  7. AstraZeneca Pharmaceuticals LP $416 16 payments
  8. Bayer HealthCare Pharmaceuticals Inc. $382 21 payments
  9. Pfizer Inc. $372 21 payments
  10. Astellas Pharma US Inc $362 10 payments
  11. Other $2,579 128 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,237 375 payments
  2. Consulting Fee $800 1 payment
  3. Education $100 1 payment
Products named General payments · program years 2021–2025
  1. NURTEC ODT Primary Care $1,174 13 payments
  2. FreeStyle Libre 3 $507 25 payments
  3. Ozempic $492 28 payments
  4. RYBELSUS $459 26 payments
  5. Kerendia $382 21 payments
  6. MOUNJARO $358 25 payments
  7. TRELEGY ELLIPTA $335 19 payments
  8. NURTEC ODT Pain $320 18 payments
  9. Otezla $290 17 payments
  10. SHINGRIX $286 18 payments
  11. Other $5,791 302 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

316

Median for Physician Assistant: 241

Drug cost

$12,721

Median for Physician Assistant: $4,110

Branded share of claims

8.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 13 $10,235
Rosuvastatin Calcium Generic 63 $742
Azelastine Hcl Generic 17 $398
Levothyroxine Sodium Generic 18 $248
Doxycycline Hyclate Generic 29 $209
Fluticasone Propionate Generic 15 $208
Methocarbamol Generic 12 $120
Lisinopril Generic 22 $103
Metoprolol Succinate Generic 16 $101
Methylprednisolone Generic 14 $98

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$12,468

Medicare's payments for the services billed

Medicare patients

107

Average age 73

Services billed

276

53 women, 54 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Diabetes 25%
Ischemic heart disease 25%
Atrial fibrillation 16%
Chronic kidney disease 13%
COPD 13%
Depression 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 38 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $170
$170 — —
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $122
$122 — —
Auvelity
  • Axsome Therapeutics, Inc. $115
$115 — —
VRAYLAR
  • AbbVie, Inc. $92
$92 — —
Xhance
  • OptiNose US, Inc. $91
$91 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 38 with Patron

Records

377 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record